Savita Kulkarni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Savita Kulkarni has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Chitra S. Misra
Applied Genomics Section, Bio-Science Group, Bhabha Atomic Research Centre, Mumbai 400085, Maharashtra, India
3 shared publications- Devashish Rath
Bhabha Atomic Research Centre
3 shared publications Megha Sodani
Radiation Medicine Centre, Medical Group, Bhabha Atomic Research Centre, Mumbai 400085, Maharashtra, India; Homi Bhabha National Institute, Training School Complex, Anushaktinagar, Mumbai 400094, Maharashtra, India
3 shared publicationsDevavrat Tripathi
Tuberculosis Immunology and Immunoassay Development Section, Radiation Medicine Centre, Bhabha Atomic Research Centre, Mumbai, India
2 shared publicationsM.G.R. Rajan
Bhabha Atomic Research Centre, Trombay, Mumbai 400085, India
2 shared publications- Pramod Kumar Gupta
Molecular Immunology and Tuberculosis Section, Radiation Medicine Centre, Medical Group, Bhabha Atomic Research Centre, Mumbai-400085, Maharashtra, India
2 shared publications
Latest Publications
- 21 January 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 260, 129583
MSMEG_0311 is a conserved essential polar protein involved in mycobacterium cell wall metabolism
- 21 January 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 260, 129583
MSMEG_0311 is a conserved essential polar protein involved in mycobacterium cell wall metabolism
- Open Access
- 1 January 2024
- Published by Indian Council of Agricultural Research, Directorate of Knowledge Management in Agriculture in Indian Journal of Veterinary Pathology
- Vol. 48 (1) , 35-40
Correlation of pendrin expression with 131Iodine uptake in post-Nal treated thyroid cancer animal model
Radioactive iodine (RAI) refractoriness develops in the background of a loss of thyroid differentiation features representing major therapeutic challenges in thyroid cancer management. Several studies have reported decreased or even loss of pendrin (SLC26A4 gene) expression in thyroid cancers, signifying the role of pendrin in the impaired ability of thyroid cancer cells for uptake and concentration of iodine. As acute iodide treatment has been shown to increase SLC26A4 mRNA, the study of pendrin expression in malignant tissues is of interest. Hence, we focused on evaluating the pendrin expression and 131I uptake in an N-bis-(2-hydroxypropyl) nitrosamine (DHPN) induced thyroid cancer model in Wistar rats followed by a single dose of excess sodium iodide (NaI) treatment to see if any change occurs in the RAI uptake. 131I uptake by scintigraphy showed thyroid standard uptake values of 10.16±1.6 and 13.13±0.115 in DHPN-treated and control groups respectively at 24 h. However, post-NaI treatment decreasing patterns at 24 h, 48 h and 72 h were observed in a few animals similar to the control. However, the rising pattern of 131I uptake was also observed in a few DHPN-induced thyroid cancer animals compared to the control. In conclusion, further extensive research is warranted to corroborate the role of NaI in the expression of pendrin in conjunction with animal species and age, along with the dose and exposure time of NaI. In addition, the expression and quantification of pendrin at the molecular level could be potentially used to enhance its utility in the management of RAI refractory human thyroid cancer patients.
- 1 January 2024
- Published by Indian Council of Agricultural Research, Directorate of Knowledge Management in Agriculture in Indian Journal of Veterinary Pathology
- Vol. 48 (1) , 35-40
Open AccessCorrelation of pendrin expression with 131Iodine uptake in post-Nal treated thyroid cancer animal model
Radioactive iodine (RAI) refractoriness develops in the background of a loss of thyroid differentiation features representing major therapeutic challenges in thyroid cancer management. Several studies have reported decreased or even loss of pendrin (SLC26A4 gene) expression in thyroid cancers, signifying the role of pendrin in the impaired ability of thyroid cancer cells for uptake and concentration of iodine. As acute iodide treatment has been shown to increase SLC26A4 mRNA, the study of pendrin expression in malignant tissues is of interest. Hence, we focused on evaluating the pendrin expression and 131I uptake in an N-bis-(2-hydroxypropyl) nitrosamine (DHPN) induced thyroid cancer model in Wistar rats followed by a single dose of excess sodium iodide (NaI) treatment to see if any change occurs in the RAI uptake. 131I uptake by scintigraphy showed thyroid standard uptake values of 10.16±1.6 and 13.13±0.115 in DHPN-treated and control groups respectively at 24 h. However, post-NaI treatment decreasing patterns at 24 h, 48 h and 72 h were observed in a few animals similar to the control. However, the rising pattern of 131I uptake was also observed in a few DHPN-induced thyroid cancer animals compared to the control. In conclusion, further extensive research is warranted to corroborate the role of NaI in the expression of pendrin in conjunction with animal species and age, along with the dose and exposure time of NaI. In addition, the expression and quantification of pendrin at the molecular level could be potentially used to enhance its utility in the management of RAI refractory human thyroid cancer patients.
- Open Access
- 1 October 2023
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 38 (4) , 328-333
Evaluation of Pendrin Expression Using Nuclear Imaging Modalities and Immunohistochemistry in Animal Thyroid Cancer Model
Context: The impaired ability of thyroid cancer (TC) cells to uptake and concentrate iodine represents a major therapeutic challenge in malignant TC management. This has been reported probably due to reduced or loss of expression of pendrin in thyroid tumors. Aims: In view of this, we evaluated the pendrin expression in the chemically induced (using N-bis[2-hydroxypropyl] nitrosamine [DHPN]) TC model in Wistar rats. Methods: Uptake in the thyroid gland was evaluated by positron emission tomography with computed tomography (PET-CT) and scintigraphy imaging. Further histopathology (HP) and immunohistochemistry (IHC) were performed for confirming malignancy. Results: The altered uptake in the thyroid gland was observed by PET-CT and scintigraphy imaging. Significant pathological changes in the thyroid were observed using 2-deoxy-2-(fluorine-18) fluoro-D-glucose PET-CT, technetium-99m pertechnetate imaging, and reduced iodine-131 uptake ( n = 4) in DHPN-induced animals compared to control indicative of thyroid cell proliferation. In treated groups, tissue HP revealed hyperplastic follicular to papillary cell proliferation with variable mitotic activity. The malignant nature of the tissue and variable uptake of the tracer were further reconfirmed by IHC. IHC revealed reduced pendrin expression in malignant thyroid tissue. Conclusions: Hence, nuclear imaging techniques can be of aid in the early identification and evaluation of cellular changes during the early development of tumor models in laboratory animals. In conclusion, our study reveals that pendrin expression plays a vital role in thyroid uptake, and its reduction was observed in TC in a chemically induced TC model.
- 1 October 2023
- Published by Scientific Scholar in Indian Journal of Nuclear Medicine
- Vol. 38 (4) , 328-333
Open AccessEvaluation of Pendrin Expression Using Nuclear Imaging Modalities and Immunohistochemistry in Animal Thyroid Cancer Model
Context: The impaired ability of thyroid cancer (TC) cells to uptake and concentrate iodine represents a major therapeutic challenge in malignant TC management. This has been reported probably due to reduced or loss of expression of pendrin in thyroid tumors. Aims: In view of this, we evaluated the pendrin expression in the chemically induced (using N-bis[2-hydroxypropyl] nitrosamine [DHPN]) TC model in Wistar rats. Methods: Uptake in the thyroid gland was evaluated by positron emission tomography with computed tomography (PET-CT) and scintigraphy imaging. Further histopathology (HP) and immunohistochemistry (IHC) were performed for confirming malignancy. Results: The altered uptake in the thyroid gland was observed by PET-CT and scintigraphy imaging. Significant pathological changes in the thyroid were observed using 2-deoxy-2-(fluorine-18) fluoro-D-glucose PET-CT, technetium-99m pertechnetate imaging, and reduced iodine-131 uptake ( n = 4) in DHPN-induced animals compared to control indicative of thyroid cell proliferation. In treated groups, tissue HP revealed hyperplastic follicular to papillary cell proliferation with variable mitotic activity. The malignant nature of the tissue and variable uptake of the tracer were further reconfirmed by IHC. IHC revealed reduced pendrin expression in malignant thyroid tissue. Conclusions: Hence, nuclear imaging techniques can be of aid in the early identification and evaluation of cellular changes during the early development of tumor models in laboratory animals. In conclusion, our study reveals that pendrin expression plays a vital role in thyroid uptake, and its reduction was observed in TC in a chemically induced TC model.
- Open Access
MSMEG_0311 is a conserved essential polar protein involved in mycobacterium cell wall metabolism
Cell wall synthesis and cell division are two closely linked pathways in a bacterial cell which distinctly influence the growth and survival of a bacterium. This requires an appreciable coordination between the two processes, more so, in case of mycobacteria with an intricate multi-layered cell wall structure. In this study, we investigated a conserved gene cluster and show that knockdown of most of the genes in this cluster leads to growth defects. We further characterised one of the genes, MSMEG_0311. The repression of this gene not only imparts severe growth defect but also changes colony morphology. We demonstrate that the protein preferentially localises to the polar region and show its influence on the polar growth of the bacillus. A combination of permeability and drug susceptibility assay strongly suggests a cell wall associated function of this gene which is also corroborated by transcriptomic analysis of the knockdown. Considering the gene is highly conserved across mycobacterial species and appears to be essential for growth, it may serve as a potential drug target.
Open AccessMSMEG_0311 is a conserved essential polar protein involved in mycobacterium cell wall metabolism
Cell wall synthesis and cell division are two closely linked pathways in a bacterial cell which distinctly influence the growth and survival of a bacterium. This requires an appreciable coordination between the two processes, more so, in case of mycobacteria with an intricate multi-layered cell wall structure. In this study, we investigated a conserved gene cluster and show that knockdown of most of the genes in this cluster leads to growth defects. We further characterised one of the genes, MSMEG_0311. The repression of this gene not only imparts severe growth defect but also changes colony morphology. We demonstrate that the protein preferentially localises to the polar region and show its influence on the polar growth of the bacillus. A combination of permeability and drug susceptibility assay strongly suggests a cell wall associated function of this gene which is also corroborated by transcriptomic analysis of the knockdown. Considering the gene is highly conserved across mycobacterial species and appears to be essential for growth, it may serve as a potential drug target.
- Open Access
- 31 July 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1233630
Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of Mycobacterium tuberculosis through induction of autophagy and augment anti-TB activity of isoniazid in RAW 264.7 macrophages
Rapid emergence of antibiotic resistance in tuberculosis has left us with limited resources to treat and manage multi drug resistant (MDR) cases of tuberculosis, prompting the development of novel therapeutics. Mycobacterium tuberculosis (MTB) perturbs the host protective pathways for its survival, therefore host directed therapeutic (HDT) interventions offer an attractive alternative strategy. Curcumin (CMN), the principle curcuminoid from Curcuma longa is known to have anti-TB activity against MDR strains of MTB in macrophages. We discovered that treatment of CMN induced autophagy in uninfected and MTB infected macrophages which was evident by conversion of LC3-I to LC3-II and degradation of p62. Inhibition of autophagy by a pharmacological inhibitor 3-MA resulted in significant inhibition of intracellular killing activity of CMN, suggesting the involvement of autophagy in intracellular clearance of MTB. Moreover, annexin v-FITC/PI staining data suggested induction of apoptosis in uninfected and MTB infected macrophages post CMN treatment. This finding was further corroborated by up-regulated expression of pro-apoptotic proteins, Bax, cleaved caspase-3 and PARP and diminished expression of anti-apoptotic protein Bcl-2 as evaluated by immunoblotting. Using GFP-MTB H37Rv and Lysotracker Red staining we demonstrated co-localization of GFP-MTB H37Rv containing phagosome to lysosome after CMN treatment, indicating enhanced phagosome lysosome fusion. Due to poor bioavailability of CMN, its clinical use is limited, therefore to overcome this issue, CMN was encapsulated in Poly(lactic-co-glycolic) acid (PLGA) shell, resulting in polymeric CMN nano particles (ISCurNP). Flow cytometric evaluation suggested >99% uptake of ISCurNP after 3h of treatment. In BALB/c mice, oral dose of ISCurNP resulted in 6.7-fold increase in the bioavailability compared to free CMN. Moreover, ISCurNP treatment resulted in significant decrease in the intracellular survival of MTB H37Rv through induction of autophagy. Adjunct action of ISCurNP and CMN in combination with isoniazid (INH) revealed >99% decrease in intracellular survival of MTB in macrophage as compared to ISCurNP, CMN or INH alone. In conclusion, our findings suggest the role of ISCurNP as novel host directed formulation to combat both sensitive and MDR strains of MTB by induction of autophagy.
- 31 July 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1233630
Open AccessMacrophage targeted polymeric curcumin nanoparticles limit intracellular survival of Mycobacterium tuberculosis through induction of autophagy and augment anti-TB activity of isoniazid in RAW 264.7 macrophages
Rapid emergence of antibiotic resistance in tuberculosis has left us with limited resources to treat and manage multi drug resistant (MDR) cases of tuberculosis, prompting the development of novel therapeutics. Mycobacterium tuberculosis (MTB) perturbs the host protective pathways for its survival, therefore host directed therapeutic (HDT) interventions offer an attractive alternative strategy. Curcumin (CMN), the principle curcuminoid from Curcuma longa is known to have anti-TB activity against MDR strains of MTB in macrophages. We discovered that treatment of CMN induced autophagy in uninfected and MTB infected macrophages which was evident by conversion of LC3-I to LC3-II and degradation of p62. Inhibition of autophagy by a pharmacological inhibitor 3-MA resulted in significant inhibition of intracellular killing activity of CMN, suggesting the involvement of autophagy in intracellular clearance of MTB. Moreover, annexin v-FITC/PI staining data suggested induction of apoptosis in uninfected and MTB infected macrophages post CMN treatment. This finding was further corroborated by up-regulated expression of pro-apoptotic proteins, Bax, cleaved caspase-3 and PARP and diminished expression of anti-apoptotic protein Bcl-2 as evaluated by immunoblotting. Using GFP-MTB H37Rv and Lysotracker Red staining we demonstrated co-localization of GFP-MTB H37Rv containing phagosome to lysosome after CMN treatment, indicating enhanced phagosome lysosome fusion. Due to poor bioavailability of CMN, its clinical use is limited, therefore to overcome this issue, CMN was encapsulated in Poly(lactic-co-glycolic) acid (PLGA) shell, resulting in polymeric CMN nano particles (ISCurNP). Flow cytometric evaluation suggested >99% uptake of ISCurNP after 3h of treatment. In BALB/c mice, oral dose of ISCurNP resulted in 6.7-fold increase in the bioavailability compared to free CMN. Moreover, ISCurNP treatment resulted in significant decrease in the intracellular survival of MTB H37Rv through induction of autophagy. Adjunct action of ISCurNP and CMN in combination with isoniazid (INH) revealed >99% decrease in intracellular survival of MTB in macrophage as compared to ISCurNP, CMN or INH alone. In conclusion, our findings suggest the role of ISCurNP as novel host directed formulation to combat both sensitive and MDR strains of MTB by induction of autophagy.
- 2 February 2023
- Published by Elsevier in Microbiological Research
- Vol. 270, 127319
Harnessing CRISPR-Cas9 as an anti-mycobacterial system
- 2 February 2023
- Published by Elsevier in Microbiological Research
- Vol. 270, 127319
Harnessing CRISPR-Cas9 as an anti-mycobacterial system
- 1 December 2021
- Published by Elsevier in Toxicology in Vitro
- Vol. 77, 105244
Butein induces intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in a human papillary thyroid cancer cell line
- 1 December 2021
- Published by Elsevier in Toxicology in Vitro
- Vol. 77, 105244
Butein induces intrinsic pathway of apoptosis, vimentin proteolysis, and inhibition of cancer stem cell population in a human papillary thyroid cancer cell line
- 1 September 2017
- Published by Elsevier in International Immunopharmacology
- Vol. 50, 168-177
Activation of murine macrophages by G1-4A, a polysaccharide from Tinospora cordifolia, in TLR4/MyD88 dependent manner
- 1 September 2017
- Published by Elsevier in International Immunopharmacology
- Vol. 50, 168-177
Activation of murine macrophages by G1-4A, a polysaccharide from Tinospora cordifolia, in TLR4/MyD88 dependent manner